Results 151 to 160 of about 4,608 (197)

What a Patient With Refractory Idiopathic Detrusor Overactivity Should Know About Botulinum Neurotoxin Type A Injection

Journal of Urology, 2009
We documented the effects of intradetrusor injections of botulinum neurotoxin type A (Botox(R)) for refractory idiopathic detrusor overactivity so that prospective patients maybe properly informed about possible improvement in quality of life, the duration of interinjection intervals and the risk of clean intermittent self-catheterization.A total of 81
Khan, Shahid, Kessler, Thomas M, Apostolidis, Apostolos, Kalsi, Vinay, Panicker, Jalesh, Roosen, Alexander, Gonzales, Gwen, Haslam, Collete, Elneil, Sohier, Fowler, Clare J, Dasgupta, Prokar   +10 more
openaire   +5 more sources

Botulinum neurotoxin type A injection of the pelvic floor muscle in pain due to spasticity: a review of the current literature

International Urogynecology Journal, 2013
The role of muscle spasm is not a new concept in the genesis of pain. Botulinum neurotoxin type A (BoNTA) has been successfully employed in a variety of muscular and inflammatory conditions. The aim of our study was to review the published literature on the role of BoNTA injection of the pelvic floor muscle in the management of women with chronic ...
A. A. Bhide, PUCCINI, FEDERICA, V. Khullar, S. Elneil, G. A. Digesu   +4 more
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Delphi Analysis: Anatomy and Botulinum Neurotoxin Type A (BoNT-A) Injection Training for Spasticity and Dystonia

Toxicon
Tobias Bäumer, Fernando Pagan, Rajiv Reebye   +2 more
exaly   +2 more sources

Botulinum Neurotoxin Type A Injections for Vaginismus Secondary to Vulvar Vestibulitis Syndrome

Obstetrics & Gynecology, 2009
To investigate whether botulinum neurotoxin type A improves vaginismus and study its efficacy with repeated treatments.Outpatients were referred because standard cognitive-behavioral and medical treatment for vaginismus and vulvar vestibular syndrome failed.
Laura, Bertolasi, Emma, Frasson, Jee Yun, Cappelletti, Silvana, Vicentini, Monia, Bordignon, Alessandra, Graziottin   +5 more
openaire   +2 more sources

Assay of diffusion of different botulinum neurotoxin type a formulations injected in the mouse leg

Muscle & Nerve, 2009
AbstractBotulinum neurotoxin type‐A (BoNT/A) is very effective in the therapy of a wide range of human syndromes characterized by hyperactivity of peripheral cholinergic nerve terminals. Little diffusion of this toxin from the site of injection is commonly observed, but even minor changes in this property would greatly affect the validity of the ...
CARLI L, MONTECUCCO, CESARE, ROSSETTO, ORNELLA   +2 more
openaire   +2 more sources

Combination of W-plasty and Botulinum Neurotoxin Type A Injection for Preventing Rhytidectomy Scar in Asians

Aesthetic Plastic Surgery, 2022
This study was conducted to see if better scar results could be obtained by administering botulinum neurotoxin type A (BoNTA) injection and W-plasty incision for preventing rhytidectomy scar.All patients underwent extended deep-plane rhytidectomy in two groups. Group 1 had a straight incision line, and BoNTA was not given.
openaire   +2 more sources

Paradoxical masseteric bulging after botulinum neurotoxin type A injection

BMJ Case Reports
Paradoxical masseteric bulging refers to an unexpected occurrence of masseter muscle bulging or protrusion following the administration of botulinum toxin injections, contrary to the anticipated muscle weakening effect. It may occur secondary to toxin failing to diffuse through the entire masseter muscle due to the presence of an inferior tendon ...
Shaiba Sandhu, Jeffry Shaefer
openaire   +2 more sources

Rare and novel complications of botulinum neurotoxin type A and dermal filler injections

Clinics in Dermatology
Botulinum neurotoxin type A (BoNTA) and filler injection procedures usually provide predicted outcomes with a low incidence of complications. Most of the complications after these procedures have been extensively discussed. In this study, we report on these injectables' less well-known, recently reported, and novel complications and attempt to clarify ...
Marina, Landau, Jerome, Klein, Frank Rosengaus, Leizgold, George, Kroumpouzos   +3 more
openaire   +2 more sources

Clean Intermittent Self-Catheterization After Botulinum Neurotoxin Type A Injections

Obstetrics & Gynecology, 2009
To investigate the hypothesis that the need for clean intermittent self-catheterization after botulinum neurotoxin type A injections is outweighed by the efficacy of this treatment, so that clean intermittent self-catheterization is not a burden for patients with refractory idiopathic detrusor overactivity.Women undergoing intradetrusor injections of ...
Kessler, Thomas M., Khan, Shahid, Panicker, Jalesh, Roosen, Alexander, Elneil, Sohier, Fowler, Clare J   +5 more
openaire   +3 more sources

Early Effect on the Overactive Bladder Symptoms following Botulinum Neurotoxin Type A Injections for Detrusor Overactivity

European Urology, 2008
Limited studies to date have reported on the onset of effect of intradetrusor botulinum neurotoxin type A (BoNTA) injections when used to treat the symptoms of the overactive bladder (OAB). Furthermore, few studies have examined the effect of BoNTA on urgency and nocturia, now recognised as the most bothersome symptoms of the OAB syndrome.
Kalsi, Vinay, Apostolidis, Apostolos, Gonzales, Gwen, Elneil, Sohier, Dasgupta, Prokar, Fowler, Clare J   +5 more
openaire   +4 more sources